Vascular Fingerprint to Identify Patients at Risk for Arterial Cardiovascular Events Within the First Year After Start of Cisplatin-based Chemotherapy for Testicular Cancer: a Validation Study

Condition: Testicular Cancer

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT02573584

Sponsor: University Medical Center Groningen

Phase:

Eligibility:

• Age: minimum 18 Years maximum 50 Years
• Gender: Male

Inclusion Criteria:

1. Diagnosis of metastatic TC and an indication to start with first-line cisplatin-based chemotherapy for metastatic TC
2. Classified into IGCCCG good or intermediate prognosis group
3. Younger than 50 years of age at start of chemotherapy
4. Signed informed consent

Exclusion Criteria:

1. History of previous cardiovascular disease
2. Retroperitoneal mass > 5 cm
3. Indication for anticoagulant therapy at start of chemotherapy

View trial on ClinicalTrials.gov